Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC); Meeting, 47230 [E6-13452]
Download as PDF
<![CDATA[
47230
Federal Register / Vol. 71, No. 158 / Wednesday, August 16, 2006 / Notices
Security Number is voluntary, but it
may make searching for a record easier
and prevent delay), (c) parking space
number (if appropriate); (d) vehicle
license number (if appropriate) and (e)
for the PSC Transhare Program, the
requester must provide the commuter
card number and the dates of
participation in the Program. The
requester must also understand that the
knowing and willful request for
acquisition of a record pertaining to an
individual under false pretenses is a
criminal offense subject to a fine. An
individual who is the subject of records
maintained in this records system may
also request an accounting of
disclosures that have been made of his
or her records.
REQUESTS BY TELEPHONE:
Since positive identification of the
caller cannot be established, telephone
requests are not honored.
CONTESTING RECORD PROCEDURES:
Contact the System Manager specified
above and reasonably identify the
record, specify the information to be
contested, the corrective action sought,
and your reasons for requesting the
correction, along with supporting
information to show how the record is
inaccurate, incomplete, untimely or
irrelevant.
RECORD SOURCE CATEGORIES:
Records are developed from
information supplied by applicants and,
for handicapped parking assignments,
by physicians and supervisors.
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS
OF THE ACT:
None.
[FR Doc. E6–13389 Filed 8–15–06; 8:45 am]
BILLING CODE 4168–17–P
Place: Centers for Disease Control and
Prevention, Tom Harkin Global
Communications Center (Building 19),
1600 Clifton Road, Atlanta, GA 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people.
Purpose: The Ethics Subcommittee
will provide counsel to the ACD, CDC,
regarding a broad range of public health
ethics questions and issues arising from
programs, scientists and practitioners.
Matters to Be Discussed: Agenda
items will include discussions in Public
Health Ethics of Emergency Response;
Ethical Considerations in Pandemic
Influenza Preparedness; and Future
Direction of the Ethics Subcommittee.
Agenda items are subject to change as
priorities dictate.
FOR FURTHER INFORMATION CONTACT: For
security reasons, please contact Drue
Barrett, Ph.D., Designated Federal
Official, Ethics Subcommittee, CDC,
1600 Clifton Road, NE., M/S D–50,
Atlanta, Georgia 30333. Telephone 404/
639–4690. E-mail: dbarrett@cdc.gov.
The deadline for notification of
attendance is September 7, 2006.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: August 9, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–13452 Filed 8–15–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jlentini on PROD1PC65 with NOTICES
Ethics Subcommittee, Advisory
Committee to the Director, Centers for
Disease Control and Prevention (CDC);
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following Subcommittee meeting.
Name: Ethics Subcommittee,
Advisory Committee to the Director
(ACD), CDC.
Times and Dates: 8:30 a.m.–5 p.m.,
September 14, 2006; 8:30 a.m.–12 p.m.,
September 15, 2006.
VerDate Aug<31>2005
20:24 Aug 15, 2006
Jkt 208001
Centers for Medicare & Medicaid
Services
[CMS–6040–N]
Medicare Program; Durable Medical
Equipment, Prosthetics, Orthotics, and
Supplies (DMEPOS) Supplier
Accreditation Applications From
Independent Accrediting Bodies
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice informs
independent accreditation organizations
of an opportunity to submit an
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
application to participate in the durable
medical equipment, prosthetics,
orthotics and supplies (DMEPOS)
accreditation program. DMEPOS
accreditation is required for DMEPOS
suppliers. This notice contains
information on how to apply for CMS
approval.
DATES: Applications will be considered
if received at the appropriate address,
provided in the ADDRESSES section, no
later than 5 p.m. d.s.t, on October 2,
2006.
ADDRESSES: Applications should be sent
to: Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244. Mail stop
C3–02–16, Attention: Sandra Bastinelli.
FOR FURTHER INFORMATION CONTACT:
Sandra Bastinelli, (410) 786–3630.
SUPPLEMENTARY INFORMATION:
I. Background
Section 302(a)(1) of the Medicare
Prescription Drug, Improvement and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173) added section 1834(a)(20) of
the Social Security Act (the Act) and
requires the Secretary to establish and
implement quality standards for
suppliers of certain items, including
consumer service standards, to be
applied by recognized independent
accreditation organizations. Suppliers of
DMEPOS must comply with the quality
standards to furnish any item for which
payment is made under Medicare Part
B, and to receive and retain a provider
or supplier billing number used to
submit claims for reimbursement for
any such item for which payment may
be made under Medicare. Section
1834(a)(20)(D) of the Act requires us to
apply these quality standards to
suppliers of the following items for
which we deem the standards to be
appropriate:
• Covered items, as defined in section
1834(a)(13) of the Act, for which
payment may be made under section
1834(a) of the Act.
• Prosthetic devices, orthotics, and
prosthetics described in section
1834(h)(4) of the Act.
• Items described in section
1842(s)(2) of the Act, which include
medical supplies; home dialysis
supplies and equipment; therapeutic
shoes; parenteral and enteral nutrients,
equipment, and supplies;
electromyogram devices; salivation
devices; blood products; and transfusion
medicine.
Section 1834(a)(20)(E) of the Act
explicitly authorizes the Secretary to
establish the quality standards by
program instruction to ensure that
suppliers that wish to participate in
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 71, Number 158 (Wednesday, August 16, 2006)]
[Notices]
[Page 47230]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13452]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Ethics Subcommittee, Advisory Committee to the Director, Centers
for Disease Control and Prevention (CDC); Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention announces the following Subcommittee meeting.
Name: Ethics Subcommittee, Advisory Committee to the Director
(ACD), CDC.
Times and Dates: 8:30 a.m.-5 p.m., September 14, 2006; 8:30 a.m.-12
p.m., September 15, 2006.
Place: Centers for Disease Control and Prevention, Tom Harkin
Global Communications Center (Building 19), 1600 Clifton Road, Atlanta,
GA 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 75 people.
Purpose: The Ethics Subcommittee will provide counsel to the ACD,
CDC, regarding a broad range of public health ethics questions and
issues arising from programs, scientists and practitioners.
Matters to Be Discussed: Agenda items will include discussions in
Public Health Ethics of Emergency Response; Ethical Considerations in
Pandemic Influenza Preparedness; and Future Direction of the Ethics
Subcommittee. Agenda items are subject to change as priorities dictate.
FOR FURTHER INFORMATION CONTACT: For security reasons, please contact
Drue Barrett, Ph.D., Designated Federal Official, Ethics Subcommittee,
CDC, 1600 Clifton Road, NE., M/S D-50, Atlanta, Georgia 30333.
Telephone 404/639-4690. E-mail: dbarrett@cdc.gov. The deadline for
notification of attendance is September 7, 2006.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: August 9, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-13452 Filed 8-15-06; 8:45 am]
BILLING CODE 4163-18-P
